Telomir Pharmaceuticals, Inc.
TELO
$1.26
-$0.03-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.29M | 7.33M | 754.30K | 403.00K | 1.27M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.70K | 72.80K | 75.30K | 88.20K | 57.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.34M | 7.40M | 829.60K | 491.20K | 1.32M |
|
|
|||||
| Total Current Assets | 7.34M | 7.40M | 829.60K | 491.20K | 1.32M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.34M | 7.40M | 829.60K | 491.20K | 1.32M |
|
|
|||||
| Total Accounts Payable | 536.80K | 329.40K | 255.00K | 558.90K | 587.50K |
| Total Accrued Expenses | 417.50K | -- | -- | -- | -- |
| Short-term Debt | 473.80K | 93.40K | 93.40K | 93.40K | 93.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.43M | 422.80K | 348.40K | 652.30K | 681.00K |
|
|
|||||
| Total Current Liabilities | 1.43M | 422.80K | 348.40K | 652.30K | 681.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 473.80K | 93.40K | 93.40K | 93.40K | 93.40K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.43M | 422.80K | 348.40K | 652.30K | 681.00K |
|
|
|||||
| Common Stock & APIC | 46.92M | 45.93M | 38.33M | 32.62M | 31.24M |
| Retained Earnings | -41.01M | -38.95M | -37.85M | -32.78M | -30.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.91M | 6.98M | 481.20K | -161.10K | 643.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.91M | 6.98M | 481.20K | -161.10K | 643.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.91M | 6.98M | 481.20K | -161.10K | 643.00K |
|
|
|||||